It raised the proportion of B cells and monocytes while lowering IL-18 protein and mRNA relative expression of the pro-inflammatory cytokine IL-18 [38]. Figure 2 depicts newer treatment modalities for ALS. This evidence concerns the gene IL18 and amyotrophic lateral sclerosis.